After spending the past year extending its portfolio of continuous glucose monitors to include people who may not have ...

DXCM's top line reflects strong demand for its CGM sensors. International expansion is also driving sales higher. Gross ...

Matthew Taylor, an analyst from Jefferies, reiterated the Buy rating on Dexcom (DXCM – Research Report). The associated price target remains ...

Insulet Corporation PODD recently made its Omnipod 5 automated insulin delivery system commercially available in five more ...

Buoyed by the recent launch of Stelo and further upcoming CGM launches, Dexcom is anticipating a 14% growth in 2025 over 2024 ...

In a report released yesterday, William Plovanic from Canaccord Genuity maintained a Buy rating on Dexcom (DXCM – Research Report), with a ...

Wearable Medical Devices Market is estimated to valued USD 40.13 Bn in 2024 & expected to reach USD 111.20 Bn by 2031, exhibiting CAGR of 15.7% from 2024-2031 ...

Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin Delivery System ...

On Friday, DexCom Inc (DXCM) stock saw a decline, ending the day at $77.76 which represents a decrease of $-2.33 or -2.91% from the prior close of $80.09. The stock opened at $79.5 and touched a low ...

Shares of Lululemon Athletica Inc. ( LULU-Q +0.65% ) were higher by 0.9 per cent on Monday after it raised its ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A ...

Dexcom forecast total annual revenue largely in line with Wall Street expectations on Monday, on bets there will be strong demand for its continuous glucose monitors for diabetes patients, sending the ...